Form 4: Baxter International EVP Jeanne K. Mason Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
EVP and Chief HR Officer of Baxter International, Jeanne K. Mason, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.
Summary
- Jeanne K. Mason, EVP and Chief HR Officer of Baxter International, executed a transaction involving the company's stock on March 1, 2024.
- Mason exercised stock options to acquire 64,488 shares of common stock at a price of $37.17 per share.
- Concurrently, Mason sold 64,488 shares of common stock at a weighted average price of $40.61, with prices ranging from $40.28 to $40.93.
- The transactions were executed under a Rule 10b5-1 trading plan established on September 6, 2023.
- Additionally, 963 shares were forfeited to cover tax withholding related to the settlement of vested restricted stock units.
- Following these transactions, Mason directly owns 141,326 shares of Baxter International common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, as it simply reports facts.
Industry Context
Executive stock transactions are common and closely monitored, especially those executed under 10b5-1 plans, which are designed to prevent accusations of insider trading. The filing provides transparency into the executive's trading activity.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- Rule 10b5-1 trading plans are a standard practice among corporate executives to manage their stock transactions and avoid insider trading concerns.
- The size and frequency of these transactions are typical for executives at large, publicly traded companies like Baxter International.
Stakeholder Impact
- The transactions have a minimal direct impact on shareholders, as they represent a small fraction of the total outstanding shares.
- The filing provides transparency to stakeholders regarding executive compensation and trading activities.
Key Dates
| Date | Description |
|---|---|
| 09/06/2023 | Date of establishment of the Rule 10b5-1 trading plan. |
| 03/01/2023 | Date of grant for restricted stock units that settled on March 1, 2024. |
| 03/01/2024 | Date of stock option exercise and share sale. |
| 03/04/2024 | Expiration date of the stock options. |
| 03/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.